EUVIMEDEUVIMED entdecken
Crossref

Roxadustat Protects Against Hypoxia-Induced Organ Damage in Acute High-Altitude Models: A Pharmacodynamic Study

Frederik Olsen, Signe Larsen

Pharmaceutical Sciences and Drug Design · 2024

DOI: 10.51847/1mkgefmbqq ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Sciences and Drug Design, 2024. Verfasst von Frederik Olsen und 1 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the protective effects of roxadustat against hypoxia-induced injury during rapid ascent to high altitude. BALB/C mice were randomly assigned to receive roxadustat at doses of 7.8, 15.6, or 31.2 mg/kg, or to control groups. The anti-hypoxic efficacy of roxadustat at the recommended dose was assessed using a controlled atmospheric pressure hypoxia model. Additionally, Wistar rats were randomly allocated to groups exposed to normal oxygen, hypoxia, acetazolamide, or rox

Zitieren

APA

Olsen, F., & Larsen, S. (2024). Roxadustat Protects Against Hypoxia-Induced Organ Damage in Acute High-Altitude Models: A Pharmacodynamic Study. Pharmaceutical Sciences and Drug Design. https://doi.org/10.51847/1mkgefmbqq

Vancouver

Olsen F, Larsen S. Roxadustat Protects Against Hypoxia-Induced Organ Damage in Acute High-Altitude Models: A Pharmacodynamic Study. Pharmaceutical Sciences and Drug Design. 2024. doi:10.51847/1mkgefmbqq

BibTeX
@article{Olsen2024,
  author = {Olsen, Frederik and Larsen, Signe},
  title = {Roxadustat Protects Against Hypoxia-Induced Organ Damage in Acute High-Altitude Models: A Pharmacodynamic Study},
  journal = {Pharmaceutical Sciences and Drug Design},
  year = {2024},
  doi = {10.51847/1mkgefmbqq}
}
Kostenlos starten →